Carl
Wonders, PhD

Communications and Content Manager

Biography

Carl combines a background in neuroscience research and scientific storytelling along with experience working in a variety of government and nonprofit organizational roles. He most recently served as a science writer and editor at the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health. He’s also held scientific and science communication roles at the American Association for Cancer Research and the International Society for Stem Cell Research. He received his bachelor’s degree in neuroscience at the University of Pittsburgh and his doctoral degree in neuroscience at Weill Cornell Medical College with a dissertation on the origin and specification of cortical interneurons in the developing mammalian brain.

Articles

Articles by
Carl Wonders, PhD

Medical eyeball structure scientific illustration, 3d rendering.

Understanding the Causes of Steroid-Induced Glaucoma

A commonly used medication is linked to increased risk of glaucoma. A BrightFocus National Glaucoma Research-funded scientist is trying to understand why.
FDA sign outside building that reads, "U.S. Department of Health and Human Services, Food and Drug Administration."

FDA Approves Repurposed Anti-Depressant to Treat Alzheimer's-Associated Agitation

Auvelity, developed by Axsome Therapeutics, was approved today by the U.S. Food & Drug Administration (FDA) for the treatment of Alzheimer’s disease agitation, a common and challenging symptom that affects 40 to 60 percent of people living with Alzheimer’s.
Tau Tangles inside the neuron cells resulting in memory loss and brain damage in Alzheimer’s disease as Misfolded proteins.

Breaking News Dispatch: Alzheimer's Oral Therapies, Prevention Strategies, and Targeted Treatments Emerge

Get the latest research news from the 2026 International Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) conference.
View All Resources